Early Intervention, Reducing Exacerbations, and Emerging Evidence for Oral Therapies Based on DPP-1 Inhibition in NCFBE


Early Intervention, Reducing Exacerbations, and Emerging Evidence for Oral Therapies Based on DPP-1 Inhibition in NCFBE

Professor Michael Loebinger, MA, FRCP, PhD

Professor Michael Loebinger, MA, FRCP, PhD

Director of the Lung Division, Clinical Director of Laboratory Medicine
Deputy Medical Director, Consultant Respiratory Medicine
Royal Brompton & Harefield Hospitals
Professor of Practice (Respiratory Medicine),
National Heart and Lung Institute
Imperial College London
London, United Kingdom